Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients.

about

Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients.

Item

http://www.wikidata.org/entity/Q44104489

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@en

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@nl

type

Item

label

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@en

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@nl

prefLabel

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@en

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients.

@nl

P1476

Naturally Occurring Resistance ...... Genotype 6a-Infected Patients

@en

P2093

Guoli Lin

http://www.w3.org/2001/XMLSchema#string

Qiumin Luo

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

Zhixin Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sequence alignment with the Clustal series of programs

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures

Global epidemiology and genotype distribution of the hepatitis C virus infection

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

Clinical implications of hepatitis C viral kinetics.

Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.

P304

9849823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/9849823

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29164151

http://www.w3.org/2001/XMLSchema#string

P932

5661091

http://www.w3.org/2001/XMLSchema#string